Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × daratumumab × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 59 Recurrence 4 Immunoglobulin Light-chain Amyloidosis 3 Smoldering Multiple Myeloma 2 Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Triple Negative Breast Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Non-small Cell Lung Cancer With STK11/LKB1 Mutation 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Amyloidosis 1 Acute Kidney Injury 1

Interventions

Cyclophosphamide 38 fludarabine 24 Methotrexate 21 Vincristine 20 Cytarabine 18 fludarabine phosphate 17 blinatumomab 17 Dexamethasone 16 venetoclax 11 Melphalan 11 Granulocyte Colony-Stimulating Factor 11 Whole-Body Irradiation 10 Mycophenolic Acid 10 Mercaptopurine 10 Tacrolimus 9 Hydrocortisone 9 Filgrastim 9 Stem Cell Transplantation 8 Rituximab 8 Mesna 8 Etoposide 8 Doxorubicin 8 Calcium Dobesilate 8 Busulfan 8 pegaspargase 7 merphos 7 calaspargase pegol 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 ponatinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡